covid2019

The 44-year-old successor to billionaire ‘Bond King’ Bill Gross is retiring early to go on road trips with his kids. ‘The pandemic has caused everybody to reevaluate.’

Nick Maroutsos, head of global bonds at Janus Henderson Investors, told Bloomberg he will retire in October. The 44-year-old said the pandemic had made him reevaluate his life. He wanted to spend time with his kids, he said. Maroutsos took over from legendary billionaire “Bond King” Bill Gross in 2019. See more stories on Insider’s … Read more

Over 300 pharma, healthcare companies eligible for new Covid loans

As many as 354 Crisil-rated companies, predominantly pharmaceutical firms and hospitals, with an aggregate bank exposure of Rs 40,000 crore will be eligible for Covid loans from lenders under RBI’s liquidity facility. Though pharmaceutical firms account for 68 per cent of rated bank exposure, hospitals (about 24 per cent of rated exposure) are likely … Read more

Vaccitech, startup behind Oxford Covid vaccine tech, falls 20% in Nasdaq debut

American depositary shares of Vaccitech fell nearly 20% in their Nasdaq debut on Friday, giving the co-inventor of the Covid-19 vaccine developed by AstraZeneca Plc and Oxford University a market value of about $464 million. The biotech firm’s shares opened at $13.62, below the initial public offering (IPO) price of $17 apiece for 6.5 million … Read more

Borosil unveils COVID-19 relief for staff

Borosil Ltd. and Borosil Renewables Ltd. said the event of an employee losing life due to Covid-19, his/her family will continue to receive the salary for the next two years (in addition to all the other benefits they are entitled to). “The company will also take care of the education of the children till their … Read more

3 reasons the stock market rally is set to continue despite recent volatility, according to UBS Wealth Management

The VIX index, a prominent gauge of market volatility, is up roughly 11% since last Friday. UBS Global Wealth Management’s Mark Haefele says the rally in equities is set to continue despite recent volatility. Haefele believes rising vaccinations, strong corporate earnings, and lower than expected inflation figures will buoy stocks. Sign up here for our … Read more

American billionaires added $1.62 trillion to their wealth over the last 13 months

These gains could signal that inequality keeps increasing during the pandemic. Over the last 13 months, American billionaires added $1.62 trillion to their wealth – a 55% increase. This was a finding in the latest report from the left-leaning Institute for Policy Studies (IPS) and Americans for Tax Fairness (ATF). Both groups have tracked billionaire gains … Read more

We will have to co-exist with virus for now:Multiplex, retail associations wary of lockdown in Maharashtra

Cinema, retail and shopping industries have just begun their recovery process and won’t be able to bear another shutdown, according to industry associations who have urged Chief Minister Uddhav Thackeray to not impose a lockdown in Maharashtra where COVID-19 cases continue to rise. The Multiplex Association of India (MAI), Retail Association of India (RAI), and … Read more

4 out of 10 Indian CEOs will prioritize employee well-being over profit: Study

Four out of 10 Indian chief executive officers (CEO) would give priority to employee well-being over near-term profit, according to a study by IBM Institute for Business Value (IBV). The findings of the study has mentioned that 41% of company CEOs in India plan to prioritize employee well-being even if it affects near-term profitability, reflecting … Read more

A Wall Street expert says the dramatic shift in stocks last week reeks of investor complacency — and warns that many favorite trades remain vulnerable to losses

The popular momentum trade that involves buying market winners and selling losers suffered its largest one-day outflow in over three decades last week Monday. This dramatic shift marked a departure from stocks geared towards working from home, and reflected investors’ excitement about an effective vaccine. But Peter Tchir, the head of macro strategy at Academy … Read more